“Adding Cynthia Kilroy and Dr. Frank Cockerill to our Strategic Advisory Board is important to the growth and success of our company,” said Chase Spurlock, PhD, founder and CEO of Decode Health.
NASHVILLE, Tenn. (PRWEB) November 12, 2020
Chase Spurlock, PhD, founder and CEO of Decode Health, announced the addition of two members to the company's Strategic Advisory Board. New members Cynthia Kilroy and Dr. Franklin Cockerill expand the depth and breadth of industries represented on the board, joining the eight members announced earlier in 2020 who provide guidance on technology development, partnership opportunities, and ongoing business strategies.
Decode Health’s predictive analytics solutions are used by health care providers, payers, public health officials, and policymakers to identify risk, inform care, and improve outcomes for the populations they serve. The company combines multiple data sources, including public health information, clinical data, healthcare claims, geographically targeted social determinants of health information, real-time patient survey results, and other enrichment data, to deliver actionable insights. Decode Health’s insights are extensible to multiple healthcare fronts and conditions, including chronic disease, COVID-19 spread, and now the emerging need to monitor those whose COVID-19 infection may be leading to long-term, chronic conditions.
“Adding Cynthia Kilroy and Dr. Cockerill to our Strategic Advisory Board is important to the growth and success of our company,” said Spurlock. “We’re delighted to have them join the other accomplished advisory board members who are helping us negotiate this transformational period in healthcare and our own company’s evolution.”
Franklin R. Cockerill, III, MD, FACP, FACCP, FAAM, FIDSA is currently CEO, FRC3Lab, LLC, a private consulting company for clinical diagnostic testing. Before launching his consulting company, he served as CEO, Chief Medical Officer, and board director for Analyte Health. Before joining Analyte Health, Dr. Cockerill was the Chair of the Department of Laboratory Medicine and Pathology, Mayo Clinic, and President and CEO of Mayo Medical Laboratories (MML). While at Mayo, he also carried a named professorship, the Ann and Leo Markin Professor of Medicine and Microbiology at Mayo Clinic Alix School of Medicine. Dr. Cockerill is board certified in internal medicine and infectious diseases and clinical microbiology. He practiced internal medicine and in infectious disease for over a decade before shifting his focus to clinical microbiology.
Cynthia Kilroy, MBA, is the founder of a healthcare consulting practice where she brings a unique form of creative advisory services to healthcare leaders. Before starting her consultancy, she was Vice President of Strategy and Acquisitions, Healthcare for Cognizant Technology Solutions, where she led industry strategy, deal flow, mergers and acquisitions, market development, strategic sales, and executive engagement for new value propositions and emerging technologies across Cognizant’s $3 billion healthcare portfolio. Kilroy was previously Senior Vice President of Provider Strategy for Optum Accountable Care Solutions, and she has a deep history in top-tier consulting firms and hospital systems and health plans, including Huron Consulting Group, Andersen Consulting, KPMG, El Camino Hospital, U.S. Healthcare (Aetna), Mercy Health Plan, and McKesson. She received her MBA from Duke University, Fuqua School of Business with a Health Sector Management certification. She is a frequent speaker and writer on value-based care transformation, digital platforms, and healthcare trends.
“Adding these members, with their unique experiences, adds to the breadth and depth of advising that Decode Health has at its disposal,” Spurlock added. “Dr. Cockerill’s expertise in laboratory services and diagnostic innovation will be invaluable as we advance our COVID-19 surveillance efforts and strengthen our chronic disease monitoring capabilities. Cynthia’s knowledge across all facets of the healthcare system, especially within the emerging payer-provider partnerships arena and the use of technology to deliver personalized care, will support our expanding value proposition. With their support and guidance, along with that from all of our advisors, we are well-positioned to understand and take advantage of the growth opportunities for our organization.”
About Decode Health:
Decode Health is a Nashville-based predictive analytics company deploying AI and machine learning to improve outcomes and create cost savings on two critical healthcare fronts: COVID-19 mitigation and Chronic Disease management. Decode Health’s predictive analytics derived from multiple data sources including public health information, healthcare claims, clinical information, and proprietary, geographically relevant social determinants of health, provide actionable insights early, enabling proactive care, better outcomes, and significant cost savings.